ISRCTN26185223Completed未知
Randomised Phase I/II Study with Ghrelin versus Placebo for patients with cancer-related Anorexia/Cachexia
Kantonsspital St. Gallen [St Gallen Cantonal Hospital]0 sites21 target enrollmentStarted: September 12, 2005Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 21
Study Overview
Brief Summary
2008 results in https://www.ncbi.nlm.nih.gov/pubmed/18182992 (added 07/01/2020)
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients with any type of advanced, incurable cancer, not requiring new or not being on antineoplastic treatment during the study period, with weight loss (>2% 2 months or >5% 6 months) and anorexia (VAS >3) will be eligible.
Exclusion Criteria
- •Severe structural barriers in the upper gastrointestinal tract, bowel obstruction.
Investigators
Similar Trials
Not yet recruiting
Phase 2
Multicentre Randomised trial of Ghrelin in anterior circulation ischemic stroke treated with endovascular thrombectomy. A randomized phase 2 trialischemic stroke10007963NL-OMON51856Rijnstate Ziekenhuis80
Unknown
Phase 2
Neoadjuvant Goserelin for Triple Negative Breast CancerBreast Cancer Triple NegativeNCT03444025Kasr El Aini Hospital180
Unknown
Not Applicable
Clinical trial of ghrelin administration in patients with chronic obstructive pulmonary diseaseChronic obstructive pulmonary diseaseJPRN-C000000061ational Cardiovascular Center Research Institute60
Completed
Phase 2
Unacylated Ghrelin to Improve Functioning in PADPeripheral Artery DiseaseNCT04377126Northwestern University25
Completed
Phase 2
Randomized phase II study of clinical effect of ghrelin administration for DCF with esophageal cancer patientsJPRN-UMIN000018162Osaka University School of Medicine Gastroenterological Surgery40